人民财讯8月14日电，瑞普生物（300119）8月14日晚间公告，公司及全资子公司瑞普(天津)生物药业有 限公司、瑞普(保定)生物药业有限公司近日获得由农业农村部核发的《新兽药注册证书》，新兽药名称 分别为禽腺病毒(I群，4型)蛋黄抗体、青霉素V钾可溶性粉。 ...

Core Viewpoint - The company, Reap Bio (300119.SZ), has recently received two new veterinary drug registration certificates from the Ministry of Agriculture and Rural Affairs, indicating a significant advancement in its product offerings in the animal health sector [1] Group 1: Product Details - The first product is an avian adenovirus (Group I, Type 4) yolk antibody, which is primarily used for the prevention and treatment of chicken pericardial effusion-hepatitis syndrome caused by Group I Type 4 avian adenovirus. It has the ability to neutralize the virus, alleviate hepatocyte necrosis and pericardial effusion, and promote the recovery of organ function [1] - The second product is soluble penicillin V potassium powder, which is mainly used to treat necrotic enteritis in chickens caused by Clostridium perfringens. It features a one-day withdrawal period and a zero-day egg discard period, providing core advantages in reducing drug residue risks and ensuring chicken meat food safety [1]